Editorial. Discusses the use of the retinoic acid receptor (RAR) as chemoprevention against lung cancer as proposed in a study published in the May 7, 1997 issue of the `Journal of the National Cancer Institute.' Questions raised by the study including whether exogenous chemoprevention retinoids perform better than endogenous retinoic acid effects.